Trial Site Detail

 

Drug:
DCC-3116 + Ripretinib
Trial:
A Study of DCC-3116 in Combination with Anticancer Therapies in Participants with Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Ronald Reagan UCLA Medical Center

757 Westwood Plaza     
Los Angeles , CA 90095
USA

 

Principal Investigator:
 Arun Singh, MD
Contact:
 Jacqueline Banuelos 310-869-7014, 16108 jbanuelosmurillo@mednet.ucla.edu
Activation Status of this Site:
 Active
Notes about this Site:
Ronald Reagan UCLA Medical Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.